Overview
Status
Active
Registry date
2020-01-23
Share capital
10,000.00 PLN
Registered address
ul. Poziomkowa 3A, 62-020 Swarzędz, Poland
Financials
Revenue history
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 102 days for 2021).
- 202512/07/2026
- 202414/07/2025
- 202303/07/2024
- 202219/07/2023
- 202125/10/2022
- 202009/12/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 2.51kMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 1.18kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 1.28kMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 1.06kMedianUSD 609.79kAverageUSD 11.85m
Industry
Authorized Representatives
Marta Anna Nowacka – Vice President of the Management Board
Łukasz Płatkiewicz – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tomasz Jarosław Matysiakage 48 | 100 | $1,350.62 | 50% |
Marta Anna Nowackaage 40 | 50 | $675.31 | 25% |
Maciej Stanisław Węgierskiage 42 | 50 | $675.31 | 25% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Sonomedical Pluciński, Wojciechowski, Wituskisp. j. | $1,264,523.63 | sonomedical.pl | ||
| Medaidsp. z o.o. | $1,034,514.88 | medaid.pl | ||
| Meditechsp. z o.o. | $934,565.46 | meditech.pl | ||
| PNN Pharmaceuticals sp. z o.o.sp. k. | $267,897.16 | pnn.com.pl | ||
| Medicallenssp. z o.o. | $179,960.83 | medicallens.com | ||
| Integris Medical Polskasp. z o.o. | $159,033.76 | integrismedical.pl | ||
| Aptekssp. z o.o. | $13,537.42 | apteks.com | ||
| HA Technologiessp. z o.o. | $206.67 | amalian.pl | ||
| Medventissp. z o.o. | – | medventis.pl | ||
| LAB Path Expertssp. z o.o. | – | labpathexperts.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-03 | Name change (Crossmed → Crossmed Invest) | |
| 2025-09-03 | Switch to PKD 2025 (8 PKD 2007 codes → 1 PKD 2025 code) | |
| 2020-01-23 | Entered in the register |
FAQ
The main business activity of Crossmed Invest focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on January 23, 2020.
The headquarters is located at: ul. Poziomkowa 3A, 62-020 Swarzędz.
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $1,253 in 2024, which is a decrease of 57.4% compared to 2023.
No, in 2024 the company was not profitable, reporting a net loss of $897. For comparison, in 2023 the loss was $9, representing a multi-fold increase in the loss compared to 2023.
The largest operating cost category falls under external services. This category amounted to $2,135 in 2024, representing 99% of all operating expenses.
Last updated: 2026-07-16